October 28, 2022
Via: PMLiVEThe advisory committee experts, however, voted 11 to five against the use of daprodustat in non-dialysis patients with anaemia of CKD, citing increased safety risks such as heart failure and bleeding gastric erosions. The FDA will consider the vote, feedback […]
July 15, 2021
Via: PMLiVEAZ and FibroGen are aiming for approval of roxadustat for the treatment of anaemia caused by chronic kidney disease (CKD). In briefing documents published ahead of a meeting of the Cardiovacular and Renal Drugs Advisory Committee meeting on 15 July, […]
July 19, 2024
July 11, 2024
July 11, 2024
Copyright © 2024. All rights reserved
